Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Journal of Pain Research
|
December 31, 2015
Terminology, criteria, and definitions in complex regional pain syndrome: challenges and solutions
Katherine Dutton, Geoffrey Littlejohn
Biomedicines
|
July 26, 2020
Key Milestones Contributing to the Understanding of the Mechanisms Underlying Fibromyalgia
Geoffrey Littlejohn, Emma Guymer
Seminars in Immunopathology
|
March 21, 2018
Neurogenic inflammation in fibromyalgia
Geoffrey Littlejohn, Emma Guymer
Australian Family Physician
|
November 13, 2008
Red flags in scleroderma
Qiang Li, Joanne Sahhar, Geoffrey Littlejohn
Internal Medicine Journal
|
June 17, 2021
Central sensitivity and fibromyalgia
Veronica Mezhov, Emma Guymer, Geoffrey Littlejohn
Brain Sciences
|
February 26, 2025
Neuroinflammatory and Immunological Aspects of Fibromyalgia
Kate Findeisen, Emma Guymer, Geoffrey Littlejohn
Internal Medicine Journal
|
October 24, 2023
Significant use of non-evidence-based therapeutics in a cohort of Australian fibromyalgia patients
Zachary Warren, Emma Guymer, Veronica Mezhov, et al.
European Journal of Rheumatology
|
September 23, 2020
Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis
Kathleen Tymms, Belinda Butcher, Tegan Smith, et al.
Clinical Rheumatology
|
May 4, 2007
The fibromyalgia bladder index
Kaye Brand, Geoffrey Littlejohn, Linda Kristjanson, et al.
Clinical Imaging
|
June 2, 2020
Dynamic CTA and MRA in a case of severe Raynaud's phenomenon
Jacqueline L Hislop-Jambrich, John M Troupis, Geoffrey Littlejohn, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Journal of Pain Research
|
December 31, 2015
Terminology, criteria, and definitions in complex regional pain syndrome: challenges and solutions
Katherine Dutton, Geoffrey Littlejohn
Biomedicines
|
July 26, 2020
Key Milestones Contributing to the Understanding of the Mechanisms Underlying Fibromyalgia
Geoffrey Littlejohn, Emma Guymer
Seminars in Immunopathology
|
March 21, 2018
Neurogenic inflammation in fibromyalgia
Geoffrey Littlejohn, Emma Guymer
Australian Family Physician
|
November 13, 2008
Red flags in scleroderma
Qiang Li, Joanne Sahhar, Geoffrey Littlejohn
Internal Medicine Journal
|
June 17, 2021
Central sensitivity and fibromyalgia
Veronica Mezhov, Emma Guymer, Geoffrey Littlejohn
Brain Sciences
|
February 26, 2025
Neuroinflammatory and Immunological Aspects of Fibromyalgia
Kate Findeisen, Emma Guymer, Geoffrey Littlejohn
Internal Medicine Journal
|
October 24, 2023
Significant use of non-evidence-based therapeutics in a cohort of Australian fibromyalgia patients
Zachary Warren, Emma Guymer, Veronica Mezhov, et al.
European Journal of Rheumatology
|
September 23, 2020
Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis
Kathleen Tymms, Belinda Butcher, Tegan Smith, et al.
Clinical Rheumatology
|
May 4, 2007
The fibromyalgia bladder index
Kaye Brand, Geoffrey Littlejohn, Linda Kristjanson, et al.
Clinical Imaging
|
June 2, 2020
Dynamic CTA and MRA in a case of severe Raynaud's phenomenon
Jacqueline L Hislop-Jambrich, John M Troupis, Geoffrey Littlejohn, et al.
Page
of 5